MedPath
HSA Approval

RINITYN TABLET 10 mg

SIN12067P

RINITYN TABLET 10 mg

RINITYN TABLET 10 mg

September 12, 2002

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD
Licence HolderGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

R06AX13

loratadine

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

HOVID BHD

HOVID Bhd.

Active Ingredients

LORATADINE

10.00 mg

Loratadine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

RINITYN TABLET 10 mg - HSA Approval | MedPath